Home / Compare / Retatrutide vs CagriSema
Retatrutide vs CagriSema
Retatrutide vs CagriSema: how they work, doses used, FDA status and trial weight loss (28.3% vs 20.4%), with sources.
| Retatrutide | CagriSema | |
|---|---|---|
| Works on | GIP + GLP-1 + glucagon (triple agonist) | Amylin (cagrilintide) + GLP-1 (semaglutide) |
| How it is taken | Injection, once weekly | Injection, once weekly |
| US status | Phase 3, not approved (filing planned early 2027) | Not approved (FDA decision expected late 2026) |
| Highest dose | 12 mg weekly (highest trial dose) | 2.4 mg + 2.4 mg weekly (trial) |
| Key trial | TRIUMPH-1 (phase 3) | REDEFINE 1 (phase 3) |
| Average weight loss | 28.3% at 80 weeks (12 mg weekly) | 20.4% at 68 weeks (2.4 mg + 2.4 mg weekly) |
| Placebo in that trial | not stated in our source | 3.0% |
Not a head-to-head comparison. The weight-loss numbers come from separate trials with different people, doses and lengths. A direct trial is the only way to know which works better.
How they differ
Retatrutide works on gip + glp-1 + glucagon (triple agonist); CagriSema works on amylin (cagrilintide) + glp-1 (semaglutide). Retatrutide is taken as: injection, once weekly.CagriSema is taken as: injection, once weekly.
Dose schedules and warnings: Retatrutide dosage chart ยท CagriSema dosage chart.
Questions
- Is retatrutide stronger than cagrisema?
- No trial has compared them directly. In separate trials, Retatrutide averaged 28.3% weight loss (TRIUMPH-1 (phase 3), 80 weeks) and CagriSema 20.4% (REDEFINE 1 (phase 3), 68 weeks). Different trials enroll different people over different lengths of time, so the numbers are not a fair head-to-head comparison.
- Is retatrutide FDA-approved?
- Phase 3, not approved (filing planned early 2027).
- Is cagrisema FDA-approved?
- Not approved (FDA decision expected late 2026).
Sources
- AJMC: Retatrutide achieves up to 30.3% average weight loss in phase 3 TRIUMPH-1
- Garvey et al. Coadministered cagrilintide and semaglutide in adults with overweight or obesity (REDEFINE 1). NEJM 2025
Last checked 2026-11-16. How we pick and check sources: methodology.